Global exports of drugs and medicines reached US$560.2 billion in 2025, reflecting the continued growth of the pharmaceutical industry and rising international demand for healthcare products.

Compared with US$429.6 billion in 2021, worldwide exports of pharmaceutical products increased by 30.4% over the four-year period. On a year-over-year basis, export revenues climbed 13.5% from US$491.6 billion in 2024.

The world's leading pharmaceutical-exporting countries in 2025 were Germany, Italy, Switzerland, Ireland, and Belgium. Together, these five major suppliers accounted for 46.6% of total global drugs and medicines exports, underscoring their dominant position in international pharmaceutical trade.

Regional Breakdown of Pharmaceutical Exports

Europe remained the center of global pharmaceutical exports, generating US$456.3 billion in overseas sales, equivalent to 81.5% of worldwide exports in 2025.

Asian countries ranked second, contributing 8.9% of global pharmaceutical shipments, followed by North America with 8.2%.

Other regions represented relatively small shares of the market, including:

· Latin America (0.9%), excluding Mexico but including Caribbean nations

· Oceania (0.3%), primarily Australia and New Zealand

· Africa (0.2%)

Harmonized System (HS) Codes for Drugs and Medicines

For trade classification and market research purposes, pharmaceutical products are mainly categorized under the following HS codes:

· HS Code 3003 – Medicaments consisting of two or more mixed constituents, representing 4.1% of global pharmaceutical exports.

· HS Code 3004 – Medicaments consisting of unmixed products or other mixed pharmaceutical preparations, accounting for 95.9% of worldwide exports in 2025.

Leading Drugs and Medicines Exporting Countries

The following countries recorded the highest export values for drugs and medicines in 2025:

1.Germany — US$73.3 billion (13.1%)

2.Italy — US$55.9 billion (10.0%)

3.Switzerland — US$50.9 billion (9.1%)

4.Ireland — US$40.9 billion (7.3%)

5..Belgium — US$40.0 billion (7.1%)

6.United States — US$35.8 billion (6.4%)

7.France — US$34.0 billion (6.1%)

8.Slovenia — US$32.0 billion (5.7%)

9.Netherlands — US$23.2 billion (4.1%)

10.India — US$23.0 billion (4.1%)

11.Denmark — US$20.2 billion (3.6%)

12.United Kingdom — US$18.6 billion (3.3%)

13.Spain — US$17.2 billion (3.1%)

14.China — US$9.1 billion (1.6%)

15.Sweden — US$8.5 billion (1.5%)

Collectively, these 15 countries supplied 84.2% of all drugs and medicines exported worldwide in 2025.

Fastest-Growing Pharmaceutical Exporters

Several countries achieved impressive growth in pharmaceutical exports between 2024 and 2025. The strongest performers included:

· Netherlands: +42.3%

· Italy: +41.5%

· Spain: +29.5%

· Ireland: +27.8%

These countries significantly expanded their pharmaceutical export activities and strengthened their positions in global markets.

Countries with More Moderate Growth

While still posting gains, some major exporters experienced comparatively slower growth rates during the same period:

· United States: +2.2%

· Switzerland: +0.8%

Despite modest increases, both countries remained among the world's largest pharmaceutical exporters.

Major Pharmaceutical Exporting Companies in 2025

According to Tendata's global trade database, the following companies ranked among the leading exporters of drugs and medicines in 2025: >>Find More Medicine Exporters via Tendata

1.INTERNATIONAL OPERATIONS SERVICES S A IOS SA — 4.77% market share (US$1.66 billion)

2.NOVO NORDISK A/S — 3.06% (US$1.07 billion)

3.BOEHRINGER INGELHEIM INTERNATIONAL GMBH — 2.22% (US$775.62 million)

4.NOVARTIS PHARMA AG — 2.21% (US$771.01 million)

5.JANSSEN PHARMACEUTICA NV — 1.80% (US$627.32 million)

6.F. HOFFMANN-LA ROCHE LTD — 1.52% (US$528.35 million)

7.TAKEDA PHARMACEUTICALS INTERNATIONAL AG — 1.51% (US$527.42 million)

8.ASTRAZENECA UK LTD — 1.26% (US$440.44 million)

9.SANOFI WINTHROP INDUSTRIE — 1.13% (US$393.02 million)

10.PFIZER SERVICE — 0.97% (US$338.76 million)

These companies played a key role in global pharmaceutical trade, supplying medicines and healthcare products to markets around the world throughout 2025.